Clinical Trial Update: Teriparatide for Postsurgical Hypoparathyroidism [Phase 2]

View source ↗

Summary

Phase 2 trial of teriparatide for postsurgical hypoparathyroidism was terminated; results were posted in December 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• Teriparatide (Teriparatide)

Snippet

Sponsor: Mayo Clinic | Conditions: Hypoparathyroidism Post-surgical | Phase 2 | Status: TERMINATED | Results posted: 2014-12-22